| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 |
| Sales | 2,790 | 3,920 | 3,540 | 3,320 | 2,780 |
| Sales Growth | -28.83% | +10.73% | +6.63% | +19.42% | -6.40% |
| Net Income | -7,030 | -7,390 | -7,920 | -4,630 | -5,380 |
| Net Income Growth | +4.87% | +6.69% | -71.06% | +13.94% | +7.08% |
Capsovision Inc (CV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif.
Fiscal Year End Date: 12/31